Global Bovine Vaccines Market – By Type: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Others; By Disease: Foot & Mouth Disease, Bovine Respiratory Disease, Bovine Viral Diarrhea, Brucellosis, Clostridial Diseases, Mastitis, Others; By Application: Preventive, Therapeutic, Diagnostic, Research, Others; By Administration Route: Injection, Oral, Nasal, Topical, Others; By Distribution Channel: Veterinary Hospitals, Retail Pharmacies, Online Platforms, Veterinary Clinics, Others; By End User: Dairy Farms, Beef Farms, Veterinary Clinics, Government Organizations, Research Institutes; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1. Market Overview
The global bovine vaccines market is projected to grow from 1.8 billion in 2024 to 3.4 billion by 2030, at an 8.9% CAGR, driven by rising zoonotic disease threats (e.g., lumpy skin disease, FMD) and mRNA vaccine breakthroughs.
Market Segmentation
By Vaccine Type
By Disease Indication
By Geography
2. Key Growth Drivers
Zoonotic Disease Threats
mRNA Vaccine Revolution
Government & NGO Initiatives
3. Competitive Landscape
|
Company |
Innovation |
Market Impact |
|
Zoetis |
mRNA BRD vaccine (40% mortality reduction) |
Launched in U.S. feedlots (2025). |
|
Boehringer |
LSD DNA vaccine (1-dose lifetime immunity) |
AU partnership for Africa rollout. |
|
Hester Biosciences |
Heat-stable FMD vaccine (no cold chain needed) |
Adopted in 15 African nations. |
4. Future Outlook (2025-2031)
| 1. Global Bovine Vaccines Market Research Report |
| 1.1 Study Objectives |
| 1.2 Global Bovine Vaccines Market - Overview |
| 1.3 Reason to Read This Report |
| 1.4 Methodology and Forecast Analysis |
| 2. Global Bovine Vaccines Market Research Report - Preface |
| 2.1 Global Bovine Vaccines Market Research Report – Detailed Scope and Definitions |
| 2.1.1 By Type |
| 2.1.2 By Disease |
| 2.1.3 By Application |
| 2.1.4 By Administration Route |
| 2.1.5 By Distribution Channel |
| 2.1.6 By End User |
| 2.1.7 By Region |
| 2.1.8 By Region |
| 3. Global Bovine Vaccines Market Dynamics |
| 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers |
| 3.2. Restraints – By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, By Country |
| 3.3. Opportunities – By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, By Country |
| 3.4. Trends – By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, By Country |
| 3.5. PEST Analysis |
| 3.6. Porters Five Rule Analysis |
| 3.7. Company’s Share Analysis (CSA) by Region or By Country |
| 3.8. Global Bovine Vaccines Market Research Report – DROTs Impact Analysis |
| 4. Global Bovine Vaccines Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031 |
| 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%) |
| 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031 |
| 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5. Global Bovine Vaccines Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 5.1 Inactivated Vaccines 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.2 Live Attenuated Vaccines 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.3 Toxoid Vaccines 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.4 Recombinant Vaccines 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.5 DNA Vaccines 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.6 Subunit Vaccines 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.7 Others 5.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6. Global Bovine Vaccines Market, By Disease, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 6.1 Foot & Mouth Disease 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.2 Bovine Respiratory Disease 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.3 Bovine Viral Diarrhea 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.4 Brucellosis 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.5 Clostridial Diseases 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.6 Mastitis 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.7 Others 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7. Global Bovine Vaccines Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 7.1 Preventive 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.2 Therapeutic 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.3 Diagnostic 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.4 Research 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.5 Others 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8. Global Bovine Vaccines Market, By Administration Route, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 8.1 Injection 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.2 Oral 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.3 Nasal 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.4 Topical 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.5 Others 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9. Global Bovine Vaccines Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 9.1 Veterinary Hospitals 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.2 Retail Pharmacies 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.3 Online Platforms 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.4 Veterinary Clinics 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.5 Others 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10. Global Bovine Vaccines Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 10.1 Dairy Farms 10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.2 Beef Farms 10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.3 Veterinary Clinics 10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.4 Government Organizations 10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.5 Research Institutes 10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11. Global Bovine Vaccines Market, By Region, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 11.1 North America 11.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.2 Europe 11.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.3 Asia-Pacific 11.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.4 Latin America 11.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.5 Middle East & Africa. 11.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12. Global Bovine Vaccines Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) |
| 12.1 North America |
| 12.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.2 Europe |
| 12.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.3 Asia-Pacific |
| 12.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.4 Latin America |
| 12.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.5 Middle East & Africa |
| 12.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.6 Global Bovine Vaccines Market - Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Region, 2024 - 2031 |
| 13. North America Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.1.1 Inactivated Vaccines |
| 13.1.2 Live Attenuated Vaccines |
| 13.1.3 Toxoid Vaccines |
| 13.1.4 Recombinant Vaccines |
| 13.1.5 DNA Vaccines |
| 13.1.6 Subunit Vaccines |
| 13.1.7 Others |
| 13.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.2.1 Foot & Mouth Disease |
| 13.2.2 Bovine Respiratory Disease |
| 13.2.3 Bovine Viral Diarrhea |
| 13.2.4 Brucellosis |
| 13.2.5 Clostridial Diseases |
| 13.2.6 Mastitis |
| 13.2.7 Others |
| 13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.3.1 Preventive |
| 13.3.2 Therapeutic |
| 13.3.3 Diagnostic |
| 13.3.4 Research |
| 13.3.5 Others |
| 13.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.4.1 Injection |
| 13.4.2 Oral |
| 13.4.3 Nasal |
| 13.4.4 Topical |
| 13.4.5 Others |
| 13.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.5.1 Veterinary Hospitals |
| 13.5.2 Retail Pharmacies |
| 13.5.3 Online Platforms |
| 13.5.4 Veterinary Clinics |
| 13.5.5 Others |
| 13.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.6.1 Dairy Farms |
| 13.6.2 Beef Farms |
| 13.6.3 Veterinary Clinics |
| 13.6.4 Government Organizations |
| 13.6.5 Research Institutes |
| 13.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.7.1 North America |
| 13.7.2 Europe |
| 13.7.3 Asia-Pacific |
| 13.7.4 Latin America |
| 13.7.5 Middle East & Africa. |
| 13.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.8.1 United States |
| 13.8.2 Canada |
| 13.9 North America Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 13.10 Regional Trends Analysis |
| 13.11 North America Global Bovine Vaccines Market Research Report - Company Profiles |
| 13.11.1 Company 1 (United States) |
| 13.11.2 Company 2 (Canada) |
| 13.11.3 Company 3 (Canada) |
| 14. Europe Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.1.1 Inactivated Vaccines |
| 14.1.2 Live Attenuated Vaccines |
| 14.1.3 Toxoid Vaccines |
| 14.1.4 Recombinant Vaccines |
| 14.1.5 DNA Vaccines |
| 14.1.6 Subunit Vaccines |
| 14.1.7 Others |
| 14.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.2.1 Foot & Mouth Disease |
| 14.2.2 Bovine Respiratory Disease |
| 14.2.3 Bovine Viral Diarrhea |
| 14.2.4 Brucellosis |
| 14.2.5 Clostridial Diseases |
| 14.2.6 Mastitis |
| 14.2.7 Others |
| 14.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.3.1 Preventive |
| 14.3.2 Therapeutic |
| 14.3.3 Diagnostic |
| 14.3.4 Research |
| 14.3.5 Others |
| 14.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.4.1 Injection |
| 14.4.2 Oral |
| 14.4.3 Nasal |
| 14.4.4 Topical |
| 14.4.5 Others |
| 14.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.5.1 Veterinary Hospitals |
| 14.5.2 Retail Pharmacies |
| 14.5.3 Online Platforms |
| 14.5.4 Veterinary Clinics |
| 14.5.5 Others |
| 14.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.6.1 Dairy Farms |
| 14.6.2 Beef Farms |
| 14.6.3 Veterinary Clinics |
| 14.6.4 Government Organizations |
| 14.6.5 Research Institutes |
| 14.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.7.1 North America |
| 14.7.2 Europe |
| 14.7.3 Asia-Pacific |
| 14.7.4 Latin America |
| 14.7.5 Middle East & Africa. |
| 14.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.8.1 Germany |
| 14.8.2 United Kingdom |
| 14.8.3 France |
| 14.8.4 Spain |
| 14.8.5 Italy |
| 14.8.6 Russia |
| 14.8.7 Netherlands |
| 14.8.8 Poland |
| 14.8.9 Rest of Europe |
| 14.9 Europe Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 14.10 Regional Trends Analysis |
| 14.11 Europe Global Bovine Vaccines Market Research Report - Company Profiles |
| 14.11.1 Company 1 (Germany) |
| 14.11.2 Company 2 (United Kingdom) |
| 14.11.3 Company 3 (United Kingdom) |
| 15. Asia-Pacific Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 15.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.1.1 Inactivated Vaccines |
| 15.1.2 Live Attenuated Vaccines |
| 15.1.3 Toxoid Vaccines |
| 15.1.4 Recombinant Vaccines |
| 15.1.5 DNA Vaccines |
| 15.1.6 Subunit Vaccines |
| 15.1.7 Others |
| 15.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.2.1 Foot & Mouth Disease |
| 15.2.2 Bovine Respiratory Disease |
| 15.2.3 Bovine Viral Diarrhea |
| 15.2.4 Brucellosis |
| 15.2.5 Clostridial Diseases |
| 15.2.6 Mastitis |
| 15.2.7 Others |
| 15.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.3.1 Preventive |
| 15.3.2 Therapeutic |
| 15.3.3 Diagnostic |
| 15.3.4 Research |
| 15.3.5 Others |
| 15.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.4.1 Injection |
| 15.4.2 Oral |
| 15.4.3 Nasal |
| 15.4.4 Topical |
| 15.4.5 Others |
| 15.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.5.1 Veterinary Hospitals |
| 15.5.2 Retail Pharmacies |
| 15.5.3 Online Platforms |
| 15.5.4 Veterinary Clinics |
| 15.5.5 Others |
| 15.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.6.1 Dairy Farms |
| 15.6.2 Beef Farms |
| 15.6.3 Veterinary Clinics |
| 15.6.4 Government Organizations |
| 15.6.5 Research Institutes |
| 15.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.7.1 North America |
| 15.7.2 Europe |
| 15.7.3 Asia-Pacific |
| 15.7.4 Latin America |
| 15.7.5 Middle East & Africa. |
| 15.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.8.1 China |
| 15.8.2 Japan |
| 15.8.3 India |
| 15.8.4 South Korea |
| 15.8.5 Australia & NZ |
| 15.8.6 ASEAN |
| 15.8.7 Rest of Asia-Pacific |
| 15.9 Asia-Pacific Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 15.10 Regional Trends Analysis |
| 15.11 Asia-Pacific Global Bovine Vaccines Market Research Report - Company Profiles |
| 15.11.1 Company 1 (China) |
| 15.11.2 Company 2 (Japan) |
| 15.11.3 Company 3 (Japan) |
| 16. Latin America Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 16.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.1.1 Inactivated Vaccines |
| 16.1.2 Live Attenuated Vaccines |
| 16.1.3 Toxoid Vaccines |
| 16.1.4 Recombinant Vaccines |
| 16.1.5 DNA Vaccines |
| 16.1.6 Subunit Vaccines |
| 16.1.7 Others |
| 16.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.2.1 Foot & Mouth Disease |
| 16.2.2 Bovine Respiratory Disease |
| 16.2.3 Bovine Viral Diarrhea |
| 16.2.4 Brucellosis |
| 16.2.5 Clostridial Diseases |
| 16.2.6 Mastitis |
| 16.2.7 Others |
| 16.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.3.1 Preventive |
| 16.3.2 Therapeutic |
| 16.3.3 Diagnostic |
| 16.3.4 Research |
| 16.3.5 Others |
| 16.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.4.1 Injection |
| 16.4.2 Oral |
| 16.4.3 Nasal |
| 16.4.4 Topical |
| 16.4.5 Others |
| 16.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.5.1 Veterinary Hospitals |
| 16.5.2 Retail Pharmacies |
| 16.5.3 Online Platforms |
| 16.5.4 Veterinary Clinics |
| 16.5.5 Others |
| 16.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.6.1 Dairy Farms |
| 16.6.2 Beef Farms |
| 16.6.3 Veterinary Clinics |
| 16.6.4 Government Organizations |
| 16.6.5 Research Institutes |
| 16.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.7.1 North America |
| 16.7.2 Europe |
| 16.7.3 Asia-Pacific |
| 16.7.4 Latin America |
| 16.7.5 Middle East & Africa. |
| 16.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.8.1 Brazil |
| 16.8.2 Mexico |
| 16.8.3 Argentina |
| 16.8.4 Peru |
| 16.8.5 Colombia |
| 16.8.6 Rest of Latin America |
| 16.9 Latin America Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 16.10 Regional Trends Analysis |
| 16.11 Latin America Global Bovine Vaccines Market Research Report - Company Profiles |
| 16.11.1 Company 1 (Brazil) |
| 16.11.2 Company 2 (Mexico) |
| 16.11.3 Company 3 (Mexico) |
| 17. Middle East & Africa Global Bovine Vaccines Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 17.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.1.1 Inactivated Vaccines |
| 17.1.2 Live Attenuated Vaccines |
| 17.1.3 Toxoid Vaccines |
| 17.1.4 Recombinant Vaccines |
| 17.1.5 DNA Vaccines |
| 17.1.6 Subunit Vaccines |
| 17.1.7 Others |
| 17.2 By Disease Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.2.1 Foot & Mouth Disease |
| 17.2.2 Bovine Respiratory Disease |
| 17.2.3 Bovine Viral Diarrhea |
| 17.2.4 Brucellosis |
| 17.2.5 Clostridial Diseases |
| 17.2.6 Mastitis |
| 17.2.7 Others |
| 17.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.3.1 Preventive |
| 17.3.2 Therapeutic |
| 17.3.3 Diagnostic |
| 17.3.4 Research |
| 17.3.5 Others |
| 17.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.4.1 Injection |
| 17.4.2 Oral |
| 17.4.3 Nasal |
| 17.4.4 Topical |
| 17.4.5 Others |
| 17.5 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.5.1 Veterinary Hospitals |
| 17.5.2 Retail Pharmacies |
| 17.5.3 Online Platforms |
| 17.5.4 Veterinary Clinics |
| 17.5.5 Others |
| 17.6 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.6.1 Dairy Farms |
| 17.6.2 Beef Farms |
| 17.6.3 Veterinary Clinics |
| 17.6.4 Government Organizations |
| 17.6.5 Research Institutes |
| 17.7 By Region Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.7.1 North America |
| 17.7.2 Europe |
| 17.7.3 Asia-Pacific |
| 17.7.4 Latin America |
| 17.7.5 Middle East & Africa. |
| 17.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.8.1 Saudi Arabia |
| 17.8.2 UAE |
| 17.8.3 South Africa |
| 17.8.4 Egypt |
| 17.8.5 Israel |
| 17.8.6 Rest of Middle East and Africa |
| 17.9 Middle East & Africa Global Bovine Vaccines Market – Opportunity Analysis Index, By Type, By Disease, By Application, By Administration Route, By Distribution Channel, By End User, By Region, and Country, 2024 - 2031 |
| 17.10 Regional Trends Analysis |
| 17.11 Middle East & Africa Global Bovine Vaccines Market Research Report - Company Profiles |
| 17.11.1 Company 1 (Saudi Arabia) |
| 17.11.2 Company 2 (UAE) |
| 17.11.3 Company 3 (UAE) |
| 18. Competition Landscape |
| 18.1 Strategic Dashboard of Top Market Players |
| 18.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis) |
| 18.2.1 Zoetis Inc. |
| 18.2.2 Merck & Co. Inc. |
| 18.2.3 Boehringer Ingelheim |
| 18.2.4 Elanco Animal Health |
| 18.2.5 Ceva Santé Animale |
| 18.2.6 Virbac |
| 18.2.7 Indian Immunologicals Ltd. |
| 18.2.8 Hester Biosciences |
| 18.2.9 Vaxxinova |
| 18.2.10 Bimeda Animal Health |
| 19. Data Collection Method and Research Approach |
| 20. Principal Presumptions and Acronyms |
Need help?
Chat with our team in a minute.